Gregory D. Davis

Insider Reports History

Location
Richmond, CA
Signature
/s/ Scott Willoughby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory D. Davis:

Company Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC Head of Research & Technology Common Stock 193,791 $80,733 $0.4166 24 Nov 2025 Direct
SANGAMO THERAPEUTICS, INC Head of Research & Technology Stock Option (Right to Buy) 99,454 25 Feb 2025 Direct

Insider Reports Filed by Gregory D. Davis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMO SANGAMO THERAPEUTICS, INC 24 Nov 2025 1 -$301 4 Head of Research & Technology 26 Nov 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 22 Oct 2025 1 -$4,427 4 Head of Research & Technology 24 Oct 2025, 17:00
SGMO SANGAMO THERAPEUTICS, INC 24 Aug 2025 1 -$424 4 Head of Research & Technology 26 Aug 2025, 20:03
SGMO SANGAMO THERAPEUTICS, INC 22 Jul 2025 1 -$3,218 4 Head of Research & Technology 24 Jul 2025, 16:55
SGMO SANGAMO THERAPEUTICS, INC 24 May 2025 1 -$342 4 Head of Research & Technology 28 May 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 22 Apr 2025 1 -$5,207 4 Head of Research & Technology 24 Apr 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2025 4 -$1,190 4 Head of Research & Technology 26 Feb 2025, 17:33
SGMO SANGAMO THERAPEUTICS, INC 22 Jan 2025 1 -$35,024 4 Head of Research & Technology 24 Jan 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 24 Nov 2024 2 -$2,335 4 Head of Research & Technology 26 Nov 2024, 16:10
SGMO SANGAMO THERAPEUTICS, INC 18 Oct 2024 0 $0 3 Head of Research & Technology 28 Oct 2024, 16:11